Pharmaceutical Industry News
Vaccines work! They have transformed the biosciences and the fight against illness, worldwide.The Lancet reported, in 2021, that vaccines administered […]
Sep 05th, 2022
Sep 05th, 2022
posted by Phill Allen
July, 28th, 2021
ALLpaQ has been named a ‘key player’ in the bioprocess containment market by a new report which explores the increasing demand of pharmaceutical, life science and biotechnology companies for sustainable secondary packaging solutions.
The research report, from Axiom Market Research & Consulting, found a thriving bioprocess containment market buoyed by increasing demand for low cost biologic drugs and considerations around the sustainability of single-use technologies.
ALLpaQ managing director, Phill Allen, welcomed the report, saying it mirrored much of the feedback around sustainable production voiced by his clients.
“At ALLpaQ, we’ve seen a massive and sustained increase in demand, as scientists around the world look to optimise and bring sustainability to their drug and vaccine production workflows,” commented Mr. Allen.
“From discovery, development, clinical testing to manufacturing, our customers’ research and drug development process is unique. That’s why we deliver the customisation they need to optimise their in-process supply chain, from clinical development stages through to commercial scale. It’s our mission to increase in-process productivity.”
The revealing research from Axiom Market Research & Consulting analyses the global bioprocess containers market by segmenting it into:
Here’s an overview of the report:
Bioprocess containers are containers system design and developed for process of manufacturing food, fed, pharmaceutical and others. In addition, single-use bioprocess containers or disposable bio manufacturing replaces stainless steel tanks, bioreactors, and plumbing with plastic, to provide flexibility, agility, and speed to the production of products. These container are widely used for cell culture products, bioprocess systems, drug discovery, and other related activities. The bioprocess containers optimize the bioprocessing approach by helping to increase the substrate range for a given cell factory. This help to reduce the cost of microbial fermentation which ultimately fuels the market growth.
Bioprocess containers market report outlook
The key factor for the growth is increasing demand for low cost biologics drugs as these drugs are made from complex molecules manufactured using living microorganisms, plants, or animal cells. Biologics include a variety of specialty medicines, vaccines, and insulin’s thereby increasing demand of bioprocess containers market. In addition, affordability and sustainability of single-use bioprocess technologies is boosting the growth owing to disposable aseptic connectivity which reduce the level of end-user manipulation within the process and therefore create greater safety. Also, vaccine production using single-use disposable technologies, and the lower risk of cross-contamination has increasing demand for bioprocess containers. Beside emergence of biopharma industry in developing economies is propelling the market growth.
COVID-19 impact on bioprocess containers market report
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360° analysis of micro and macro-economic factors on the bioprocess containers market. In addition, complete analysis of changes on the bioprocess containers market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 impact on the bioprocess containers market was moderate as the production and demand for bioprocess containers was decreased which has hampered the market growth.
PRESS NOTES TO EDITORS
Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc.
From discovery, development, clinical testing to manufacturing, your research and cell culture development process is unique. That’s why we deliver the customisation you need to optimise your in-process supply chain from clinical development stages through to commercial scale. It’s our mission to increase your in-process productivity and to change your life sciences.